Publicaciones en las que colabora con Elisa Luño Fernández (9)

2020

  1. miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk

    Leukemia, Vol. 34, Núm. 10, pp. 2648-2659

2018

  1. Clinical characteristics, prognosis and treatment of myelofibrosis patients with severe thrombocytopenia

    British Journal of Haematology

  2. Twelve years of experience with miglustat in the treatment of type 1 Gaucher disease: The Spanish ZAGAL project

    Blood Cells, Molecules, and Diseases, Vol. 68, pp. 173-179

2016

  1. Patients with type 1 Gaucher disease in Spain: A cross-sectional evaluation of health status

    Blood Cells, Molecules, and Diseases, Vol. 56, Núm. 1, pp. 23-30

2014

  1. The international prognostic scoring system does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis

    Haematologica

2013

  1. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

    Leukemia Research, Vol. 37, Núm. 7, pp. 769-776

  2. Complex, not monosomal, karyotype is the cytogenetic marker of poorest prognosis in patients with primary myelodysplastic syndrome

    Journal of Clinical Oncology, Vol. 31, Núm. 7, pp. 916-922

2011

  1. Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

    Blood Cells, Molecules, and Diseases, Vol. 46, Núm. 1, pp. 115-118

2010

  1. Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy

    Haematologica, Vol. 95, Núm. 3, pp. 424-431